CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...
Phase 2
Butler, Pennsylvania, United States and 88 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Pittsburgh, Pennsylvania, United States and 330 other locations
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...
Phase 2
Beaver, Pennsylvania, United States and 159 other locations
To evaluate the safety of tolvaptan in pediatric subjects with ARPKD
Phase 3
Pittsburgh, Pennsylvania, United States and 22 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Bridgeville, Pennsylvania, United States and 751 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Pittsburgh, Pennsylvania, United States and 762 other locations
This study is an open-label, multi-center study evaluating the clinical utility of Renasight in the diagnosis and management of kidney disease...
Pittsburgh, Pennsylvania, United States and 30 other locations
The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN.This s...
Phase 3
Uniontown, Pennsylvania, United States and 565 other locations
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fis...
Butler, Pennsylvania, United States and 17 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and ren...
Phase 3
Pittsburgh, Pennsylvania, United States and 79 other locations
Clinical trials
Research sites
Resources
Legal